Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Disappointing Clinical Trial Pummels Acadia. (cover story)
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Chambers, Heather
- Source:
San Diego Business Journal. 9/14/2009, Vol. 30 Issue 37, p1-43. 2p.
- Subject Terms:
- Additional Information
- Subject Terms:
- Subject Terms:
- Abstract:
The article reports on the failure of pimavanserin drug, developed by SorrentoValley, California-based Acadia Pharmaceuticals Inc., to prove its effectiveness to treat Parkinson's disease psychosis during the six-week, 300-person study. The result has led to the decline of Acadia's stock by two-thirds in September 2009. However, the company has continued to believe in the capacity of the drug despite the results.
No Comments.